###begin article-title 0
###xml 102 107 <span type="species:ncbi:4932">yeast</span>
Cleavage of the signaling mucin Msb2 by the aspartyl protease Yps1 is required for MAPK activation in yeast
###end article-title 0
###begin p 1
###xml 34 54 34 54 <email xmlns:xlink="http://www.w3.org/1999/xlink">pjcullen@buffalo.edu</email>
Correspondence to Paul J. Cullen: pjcullen@buffalo.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 180 204 180 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 180 204 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Signaling mucins are cell adhesion molecules that activate RAS/RHO guanosine triphosphatases and their effector mitogen-activated protein kinase (MAPK) pathways. We found that the Saccharomyces cerevisiae mucin Msb2p, which functions at the head of the Cdc42p-dependent MAPK pathway that controls filamentous growth, is processed into secreted and cell-associated forms. Cleavage of the extracellular inhibitory domain of Msb2p by the aspartyl protease Yps1p generated the active form of the protein by a mechanism incorporating cellular nutritional status. Activated Msb2p functioned through the tetraspan protein Sho1p to induce MAPK activation as well as cell polarization, which involved the Cdc42p guanine nucleotide exchange factor Cdc24p. We postulate that cleavage-dependent activation is a general feature of signaling mucins, which brings to light a novel regulatory aspect of this class of signaling adhesion molecule.
###end p 3
###begin p 4
Abbreviations used in this paper: CD, cleavage domain; co-IPT, coimmunoprecipitation; GEF, guanine nucleotide exchange factor; HOG, high osmolarity glycerol response; MHD, mucin homology domain; TM, transmembrane; WT, wild type.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 431 453 431 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">Silverman et al., 2003</xref>
###xml 564 585 564 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Carraway et al., 2007</xref>
###xml 709 738 709 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">Singh and Hollingsworth, 2006</xref>
###xml 887 905 880 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Huang et al., 2003</xref>
###xml 907 923 900 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">Wei et al., 2006</xref>
Signal transduction pathways control multiple aspects of cellular behavior, including regulating the connectivity between cells and their adhesion to external surfaces. Among the signaling proteins that regulate cell adhesion are members of the mucin family of proteins. Signaling mucins are cell-surface proteins composed of a heavily glycosylated extracellular domain that contains a Ser/Thr/Pro-rich mucin homology domain (MHD; Silverman et al., 2003), which is connected to a cytoplasmic domain that regulates RAS/RHO GTPases and their effector MAPK pathways (Carraway et al., 2007). Proteolytic processing separates the domains and results in the shedding of the extracellular glycodomain from the cell (Singh and Hollingsworth, 2006). Signaling mucins also contribute to the regulation of other pathways including the Wnt, nuclear factor-kappabeta, and estrogen receptor pathways (Huang et al., 2003; Wei et al., 2006).
###end p 6
###begin p 7
###xml 3 27 3 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 122 141 122 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Cullen et al., 2004</xref>
###xml 195 208 195 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">Johnson, 1999</xref>
###xml 315 333 315 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">Peter et al., 1996</xref>
###xml 335 355 335 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">Leberer et al., 1997</xref>
###xml 378 396 378 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">Simon et al., 1995</xref>
###xml 453 477 453 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Tatebayashi et al., 2006</xref>
###xml 557 577 557 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">Madhani et al., 1997</xref>
###xml 686 704 686 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">Butty et al., 1998</xref>
###xml 706 725 706 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">Harris et al., 2001</xref>
###xml 796 815 796 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Cullen et al., 2004</xref>
###xml 869 898 869 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">O'Rourke and Herskowitz, 2002</xref>
###xml 960 979 960 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Cullen et al., 2004</xref>
###xml 1046 1064 1046 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">Maeda et al., 1995</xref>
###xml 1066 1085 1066 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Cullen et al., 2004</xref>
###xml 1087 1109 1087 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Zarrinpar et al., 2004</xref>
###xml 1296 1315 1296 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Cullen et al., 2004</xref>
###xml 3 27 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
In Saccharomyces cerevisiae, the signaling mucin Msb2p regulates MAPK activity by interaction with the RHO GTPase Cdc42p (Cullen et al., 2004), a global regulator of cell signaling and polarity (Johnson, 1999). Cdc42p and its effector kinase Ste20p regulate multiple MAPK pathways including the filamentous growth (Peter et al., 1996; Leberer et al., 1997), pheromone response (Simon et al., 1995), and high osmolarity glycerol response (HOG) pathways (Tatebayashi et al., 2006). Differential MAPK activation is regulated in part by pathway-specific MAPKs (Madhani et al., 1997) and recruitment of core signaling modules to pathway-dedicated receptor complexes by scaffolding proteins (Butty et al., 1998; Harris et al., 2001). Msb2p is required for activation of the filamentous growth pathway (Cullen et al., 2004) and may function in a minor way in the HOG pathway (O'Rourke and Herskowitz, 2002). Indeed, Msb2p associates with the tetraspan protein Sho1p (Cullen et al., 2004), which operates in both the filamentous growth and HOG pathways (Maeda et al., 1995; Cullen et al., 2004; Zarrinpar et al., 2004). Although it is unclear how Msb2p becomes activated, loss of the MHD induces the signaling function of the protein, which suggests an inhibitory role for this domain in MAPK signaling (Cullen et al., 2004).
###end p 7
###begin p 8
In the present study, we show that Msb2p, like its mammalian counterparts, is processed into secreted and cell-associated forms. This discovery, coupled with the fact the secreted domain of Msb2p is inhibitory, suggests a mechanism where processing and release of the extracellular domain activates the protein. We confirmed this hypothesis and identified an aspartyl protease, Yps1p, that is required for Msb2p processing. Intriguingly, the gene encoding Yps1p is induced in response to nutrient limitation, which provides a straightforward mechanism for regulated processing of Msb2p. We speculate that cleavage-dependent activation may be a general feature of mucin receptors.
###end p 8
###begin title 9
Results and discussion
###end title 9
###begin title 10
Msb2p is processed into distinct polypeptides
###end title 10
###begin p 11
###xml 523 531 523 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 659 678 659 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Cullen et al., 2004</xref>
###xml 850 858 850 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 1028 1036 1028 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1127 1135 1127 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
The extracellular portion of the Msb2p protein was detected in supernatants by Western blotting, which indicates that it is secreted from the cell. To determine if secretion results from processing in the extracellular domain, a version of the protein was examined in which the extracellular (HA, at 500 residues) and cytoplasmic (GFP, at 1,306 residues) domains were differentially tagged. Conditioned media derived from cells expressing HA-Msb2p-GFP showed that the extracellular but not cytoplasmic domain was secreted (Fig. 1 A). This result confirms topological and subcellular fractionation data that indicate that Msb2p is a membrane-spanning protein (Cullen et al., 2004). Although the extracellular domain of Msb2p migrated as a single heavily glycosylated product at >250 kD, the cytoplasmic domain migrated as multiple intermediate forms (Fig. 1 A), which indicates that it is unstable. Consistent with this result, the extracellular portion of Msb2p tagged with GFP was found evenly distributed throughout the cell (Fig. 1 B), whereas the cytoplasmic domain tagged with GFP was predominately localized to vacuoles (Fig. 1 B). These results indicate that Msb2p is processed into multiple polypeptides with different stabilities and localization patterns.
###end p 11
###begin p 12
###xml 0 99 0 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Msb2p is processed in the cleavage domain and the extracellular portion of the protein is secreted.</bold>
###xml 510 514 509 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSB2</italic>
Msb2p is processed in the cleavage domain and the extracellular portion of the protein is secreted. (A) Western blot of supernatant (S) and pellet (P) fractions derived from cells containing HA-Msb2p-GFP. (left) Anti-HA antibodies. (right) Anti-GFP antibodies. The band at 25 kD migrates at the predicted size of GFP. (B) Localization of Msb2p containing GFP inserted into the extracellular and cytoplasmic domains. (top) Differential interference contrast. (bottom) FITC. Bar, 5 mum. (C) Deletion analysis of MSB2. Top lines, potential glycosylation sites; bottom lines, basic residues. (D) Western blot of S and P fractions derived from cells expressing HA-Msb2p deletions. Molecular mass standards (kD) are indicated on the left of the gel blots.
###end p 12
###begin p 13
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSB2</italic>
###xml 110 118 110 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 189 215 189 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100-818&#916;, 100&#8211;850&#916;</italic>
###xml 221 233 213 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100-900&#916;</italic>
###xml 250 265 238 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, C and D</xref>
###xml 287 299 275 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100-950&#916;</italic>
###xml 330 345 314 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, C and D</xref>
###xml 683 698 667 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, C and D</xref>
###xml 792 800 776 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 888 896 872 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 988 994 972 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TM-CYT</italic>
###xml 1001 1016 981 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, C and D</xref>
Deletion analysis of the MSB2 ORF was performed to identify the region of the protein required for secretion (Fig. 1 C). Versions of Msb2p containing deletions in the extracellular domain (100-818Delta, 100-850Delta, and 100-900Delta) were secreted (Fig. 1, C and D), as was the version 100-950Delta, although to a lesser extent (Fig. 1, C and D). Additional deletion analysis was performed using HA-Msb2p as the template because epitope fusions in the cytoplasmic domain were unstable and difficult to detect. An extracellular region of the protein adjacent to the transmembrane (TM) domain was identified that was required for secretion (cleavage domain [CD] 1,045-1,145 residues; Fig. 1, C and D). The CD overlaps with the predicted cleavage site by Western blotting (the 55-kD product in Fig. 1 A) and resides between the glycosylation-rich extracellular domain and basic C terminus (Fig. 1 C). A version of Msb2p lacking the TM and cytoplasmic domains was secreted at higher levels (TM-CYTDelta; Fig. 1, C and D), which is consistent with the idea that the TM domain anchors Msb2p to the plasma membrane.
###end p 13
###begin title 14
The aspartyl protease Yps1p processes Msb2p
###end title 14
###begin p 15
###xml 121 141 121 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">Giaever et al., 2002</xref>
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps1</italic>
###xml 433 452 429 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">Krysan et al., 2005</xref>
###xml 491 495 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps1</italic>
###xml 528 531 520 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps</italic>
###xml 548 556 540 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 575 578 567 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps</italic>
###xml 621 625 613 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps1</italic>
###xml 641 645 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps1</italic>
###xml 651 655 635 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mkc7</italic>
###xml 662 666 642 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps1</italic>
###xml 672 676 648 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps3</italic>
###xml 708 717 680 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5yps&#916;</italic>
###xml 719 727 687 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 819 823 787 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YPS1</italic>
###xml 918 927 886 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5yps&#916;</italic>
To identify the protease required for Msb2p processing, protein processing mutants from the ordered deletion collection (Giaever et al., 2002) were examined for defects in secretion of HA-Msb2p. One mutant stood out as partially defective (yps1Delta; Table S3, available at ). Yps1p is a member of a family of glycosylphosphatidylinositol (GPI)-anchored aspartyl proteases called yapsins (Yps1p, Mkc7/Yps2p, Yps3p, Yps6p, and Yps7p; Krysan et al., 2005). HA-Msb2p was poorly secreted in the yps1Delta mutant, more so than other yps single mutants (Fig. 2 A). Combinations of yps mutants showed combinatorial defects with yps1Delta including yps1Delta mkc7Delta, yps1Delta yps3Delta, and the quintuple mutant 5ypsDelta (Fig. 2 A), which indicates a minor role for other Yps proteins in Msb2p processing. Introduction of YPS1 on a centromere-based plasmid rescued the majority of the secretion defect of HA-Msb2p in the 5ypsDelta strain (Fig. S1 A), confirming that Yps1p is the primary Yps protease required for Msb2p processing.
###end p 15
###begin p 16
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The role of yapsin proteases in Msb2p processing.</bold>
###xml 115 118 115 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps</italic>
###xml 263 272 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps1&#916;</italic>
###xml 278 287 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5yps&#916;</italic>
The role of yapsin proteases in Msb2p processing. (A) Western blot analysis of the secretion defect of HA-Msb2p in yps mutants. Molecular mass standards (kD) are indicated on the left of the gel blots. P, pellet; S, supernatant. (B) Msb2p-GFP localization in WT, yps1Delta, and 5ypsDelta strains. Bar, 10 mum.
###end p 16
###begin p 17
###xml 144 168 144 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">Bourbonnais et al., 2000</xref>
###xml 339 342 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps</italic>
###xml 462 465 462 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps</italic>
###xml 584 587 584 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps</italic>
###xml 671 679 671 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps&#916;</italic>
###xml 688 696 684 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 751 754 747 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps</italic>
###xml 764 772 760 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 1002 1005 998 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps</italic>
###xml 1073 1092 1069 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">Krysan et al., 2005</xref>
###xml 1192 1201 1188 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5yps&#916;</italic>
###xml 1232 1240 1224 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 1347 1350 1333 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps</italic>
###xml 1424 1433 1410 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps1&#916;</italic>
Yps1p has been shown to process heterologously expressed glycoprotein substrates by cleavage in the extracellular domain at monobasic residues (Bourbonnais et al., 2000). By these criteria, Msb2p is a likely substrate of Yps1p and the first physiological target to be identified. Several lines of evidence support this possibility. First, yps mutants are not generally defective in protein secretion, and several proteins have been examined that are secreted in yps mutants to wild type (WT) or higher levels (unpublished data). The Msb2p protein was delivered to the cell surface in yps mutants based on the fact that HA-Msb2p lacking its TM domain was secreted in the 5ypsDelta mutant (Fig. 2 A). Intriguingly, Msb2p-GFP was absent from vacuoles in yps mutants (Fig. 2 B). Several other cell-surface proteins showed a similar localization pattern (unpublished data), which suggests a general requirement for Yps proteins in delivery of a subset of cell-surface proteins to vacuoles. Second, although yps mutants have defects in cell integrity and cell wall biosynthesis (Krysan et al., 2005), secretion of HA-Msb2p was not restored by conditional rescue of the cell integrity defect of the 5ypsDelta mutant grown in 1 M sorbitol (Fig. 2 A). Likewise, cell-wall mutant combinations defective for beta-1,3 and beta-1,6-glucan synthesis that mimic yps phenotypes showed elevated secretion of HA-Msb2p (Fig. S1 B). Third, the yps1Delta mutant was defective in processing Msb2p-TAP, resulting in accumulation of the full-length protein and loss of a processing intermediate (Fig. S1 C).
###end p 17
###begin title 18
Cleavage of Msb2p is required for MAPK activation and is stimulated by nutrient limitation-dependent induction of YPS1 expression
###end title 18
###begin p 19
###xml 69 88 69 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Cullen et al., 2004</xref>
###xml 202 210 202 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;MHD</sup>
###xml 212 220 208 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 504 511 500 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;CD</sup>
###xml 546 554 538 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 684 692 676 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
Msb2p lacking the MHD hyperactivates the filamentous growth pathway (Cullen et al., 2004). Versions of Msb2p lacking larger portions of the extracellular domain were also hyperactive, more so than Msb2pDeltaMHD (Fig. 3 A), which confirms that the extracellular domain (from 100 to 950 residues) functions in an inhibitory capacity. Cleavage of the inhibitory domain may provide an explanation for how the protein becomes activated. In support of this possibility, the noncleavable version of Msb2p, Msb2pDeltaCD, was defective for MAPK activity (Fig. 3 A) and filamentous growth (not depicted). Versions of Msb2p lacking the TM and CYT domains were similarly defective for signaling (Fig. 3 A).
###end p 19
###begin p 20
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YPS1</italic>
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cleavage of Msb2p induces MAPK signaling and is regulated at the level of <italic>YPS1</italic> expression.</bold>
###xml 95 104 95 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FUS1-lacZ</italic>
###xml 194 203 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps1&#916;</italic>
###xml 434 443 430 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YPS1-lacZ</italic>
###xml 545 554 541 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FUS1-lacZ</italic>
###xml 602 606 598 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YPS1</italic>
###xml 611 615 607 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MKC7</italic>
###xml 783 787 778 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YPS1</italic>
###xml 235 240 <span type="species:ncbi:4932">yeast</span>
Cleavage of Msb2p induces MAPK signaling and is regulated at the level of YPS1 expression. (A) FUS1-lacZ expression in strains containing Msb2p deletions. (B) Western blot of HA-Msb2p in WT and yps1Delta strains grown in mid-log phase yeast extract peptone dextrose (YEPD) or YEP-GAL (YEPG) medium for 1 and 3 d. Dpm1p was used as a loading control (Ctl). Molecular mass standards (kD) are indicated on the left of the gel blots. (C) YPS1-lacZ expression in cells incubated in mid-log phase in SCD (Glu) or SC-Gal (Gal) medium for 1and 3 d. (D) FUS1-lacZ expression in indicated strains overexpressing YPS1 and MKC7. Error bars represent the standard deviation of the values derived from at least two separate experiments. (E) Cell morphology in strains containing high copy (2 mum) YPS1. Bar, 5 mum.
###end p 20
###begin p 21
###xml 199 223 199 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Cullen and Sprague, 2000</xref>
###xml 341 349 341 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 389 398 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps1&#916;</italic>
###xml 428 436 424 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 556 560 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YPS1</italic>
###xml 594 613 590 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">Krysan et al., 2005</xref>
###xml 630 634 626 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YPS1</italic>
###xml 715 723 711 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 744 748 740 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YPS1</italic>
###xml 752 761 748 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MKC7/YPS2</italic>
###xml 851 859 847 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 883 891 879 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 E</xref>
###xml 1041 1049 1037 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
To determine if Msb2p processing is regulated, secretion of Msb2p was examined in cells incubated under different conditions, particularly nutrient limitation, a known inducer of filamentous growth (Cullen and Sprague, 2000). Secretion of HA-Msb2p was induced >10-fold by nutrient limitation, and the enhanced secretion was Yps1p dependent (Fig. 3 B). Unprocessed Msb2p accumulated in the yps1Delta mutant under this condition (Fig. 3 B). To determine how Yps1p regulates Msb2p processing in a nutrient-dependent manner, we turned to the expression of the YPS1 gene, which is highly regulated (Krysan et al., 2005). Expression of YPS1 was induced under nutrient-limiting conditions that promote filamentous growth (Fig. 3 C). Overexpression of YPS1 or MKC7/YPS2 from a high-copy plasmid or inducible promoter stimulated Msb2p-dependent MAPK activity (Fig. 3 D) and polarized growth (Fig. 3 E and not depicted). Cells lacking Yps1p were partially defective for MAPK activity, and this effect was exacerbated in cells lacking Mkc7p and Yps3p (Fig. 3 D). Therefore, Msb2p processing is regulated by starvation-dependent induction of its cognate protease. Cleavage by Yps1p may trigger Msb2p activation or be a prerequisite for activation.
###end p 21
###begin title 22
Activated Msb2p functions through Sho1p
###end title 22
###begin p 23
###xml 50 69 50 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Cullen et al., 2004</xref>
###xml 163 171 163 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHO1</italic>
###xml 499 507 499 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 569 577 569 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 686 694 686 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 822 827 822 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P120L</sup>
###xml 900 904 900 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHO1</italic>
###xml 1039 1058 1039 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Marles et al., 2004</xref>
###xml 1060 1082 1060 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Zarrinpar et al., 2004</xref>
###xml 1084 1108 1084 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Tatebayashi et al., 2006</xref>
###xml 1232 1250 1232 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">Raitt et al., 2000</xref>
Msb2p interacts with the tetraspan protein Sho1p (Cullen et al., 2004). The C-terminal domain of Msb2p was sufficient to recapitulate the Msb2p-Sho1p interaction (Fig. 4 A). To better understand the role of Sho1p in Msb2p-dependent signaling, alleles of SHO1 were isolated that hyperactivate the filamentous growth pathway. A dominant gain-of-function allele was identified by random mutagenesis that encodes a P120L change in the short DGPKK linker of the second extracellular loop of the protein (Fig. 4 B). The mutation at P120L did not affect Sho1p protein levels (Fig. 4 B) but stimulated the filamentous growth pathway based on hyperpolarized growth of haploid and diploid cells (Fig. 4 C), agar invasion phenotypes (Fig. S2 A, available at ), and induction of filamentous growth pathway reporters (Fig. S2 B). Sho1pP120L functioned normally in the HOG pathway (Fig. S2, C-F). Other alleles of SHO1 that differentially influence its function between pathways map to the cytoplasmic SH3 domain and affect the Sho1p-Pbs2p interaction (Marles et al., 2004; Zarrinpar et al., 2004; Tatebayashi et al., 2006). The P120L mutation maps to the tetraspan domain that is thought to be dispensable for Sho1p function in the HOG pathway (Raitt et al., 2000) and may identify a region of the protein that specifically regulates Sho1p function in the filamentous growth pathway.
###end p 23
###begin p 24
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Msb2p induces MAPK activation through Sho1p.</bold>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHO1</italic>
###xml 517 522 517 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P120L</sup>
###xml 610 619 610 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FUS1-lacZ</italic>
###xml 664 668 664 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHO1</italic>
###xml 673 677 673 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSB2</italic>
###xml 821 826 821 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P120L</sup>
###xml 839 851 839 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;100-818</sup>
Msb2p induces MAPK activation through Sho1p. (A) Co-IPT analysis of Sho1p-HA with N- and C-terminally tagged Msb2p-GFP. IPT, immunoprecipitation; WCE, whole cell extract. Proteins were tagged and precipitated with the indicated epitopes. The asterisks indicate the bands that correspond to GFP. Molecular mass standards (kD) are indicated on the left of the gel blots. (B) Alleles of SHO1 (P120L and S220F) that hyperactivate the filamentous growth pathway. (bottom) Western blot of Sho1p-HA protein levels. (C) Sho1pP120L induces hyperpolarized growth in haploid (in SC-Glu) and diploid cells (in SLAHD). (D) FUS1-lacZ expression in strains containing alleles of SHO1 and MSB2. Error bars represent the standard deviation of the values derived from at least two separate experiments. (E) Cell morphology induced by Sho1pP120L and Msb2p-HADelta100-818 in the indicated strains grown in SCD medium. Bars: (C) 5 mum; (E) 20 mum.
###end p 24
###begin p 25
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSB2</italic>
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHO1</italic>
###xml 199 207 199 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 236 244 236 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
###xml 265 270 265 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P120L</sup>
###xml 305 313 305 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 342 350 342 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
###xml 382 387 382 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P120L</sup>
###xml 428 435 428 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;CD</sup>
###xml 451 480 447 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps1&#916; mkc2&#916; yps3&#916;</italic>
###xml 647 655 631 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 679 683 663 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHO1</italic>
###xml 702 706 686 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">msb2</italic>
###xml 713 721 693 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 952 960 932 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 962 966 942 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHO1</italic>
###xml 966 971 946 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P120L</sup>
###xml 992 996 972 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">msb2</italic>
Gain-of-function alleles of MSB2 and SHO1 were used to explore the functional relationships between the cell-surface proteins. Activated versions of Msb2p were dependent on Sho1p for MAPK signaling (Fig. 4 D) and hyperpolarized growth (Fig. 4 E). In contrast, Sho1pP120L partially induced MAPK signaling (Fig. 4 D) and hyperpolarized growth (Fig. 4 E) in the absence of Msb2p. Sho1pP120L also restored MAPK activity to the Msb2pDeltaCD strain and the yps1Delta mkc2Delta yps3Delta mutant (not depicted). This property reflects a change in the activation state of Sho1p, as another gain-of-function allele that was present at higher levels (S220F; Fig. 4 B), or overexpression of SHO1, failed to bypass msb2Delta (Fig. 4 D, shown for S220F). These results indicate that MAPK signaling is initiated by Msb2p and propagated through Sho1p. This conclusion may oversimplify the relationship between the proteins as they show some degree of interdependence (Fig. 4 D, SHO1P120L in WT compared with msb2Delta) but is nevertheless consistent with the idea that cleavage of Msb2p is an early or initial event in MAPK activation.
###end p 25
###begin title 26
Sho1p contributes to guanine nucleotide exchange factor (GEF) polarization by multiple mechanisms
###end title 26
###begin p 27
###xml 40 59 40 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Cullen et al., 2004</xref>
###xml 111 135 111 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">Bender and Pringle, 1992</xref>
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC24</italic>
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHO1</italic>
###xml 305 313 305 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 452 475 452 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Nern and Arkowitz, 1999</xref>
###xml 639 659 639 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">Harkins et al., 2001</xref>
###xml 728 747 728 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">Taheri et al., 2000</xref>
###xml 749 773 749 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">Cullen and Sprague, 2002</xref>
###xml 864 884 864 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">Shimada et al., 2004</xref>
###xml 928 936 928 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 1237 1245 1237 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 1258 1266 1258 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 C</xref>
###xml 1292 1296 1292 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHO1</italic>
###xml 1443 1451 1443 1451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 D</xref>
Msb2p interacts with the GTPase Cdc42p (Cullen et al., 2004) and has genetic interactions with the GEF Cdc24p (Bender and Pringle, 1992). CDC24 showed genetic interactions with SHO1 and other filamentous growth pathway components (Fig. S3 A, available at ). The Cdc24p protein also associated with Sho1p (Fig. 5 A); an interaction with Msb2p was not detected (not depicted). Given the complex associations between receptors and GEFs in other contexts (Nern and Arkowitz, 1999), it is possible that the Sho1p-Cdc24p interaction is mediated by other proteins. We also tested for an interaction between Sho1p and the positional marker Bud8p (Harkins et al., 2001), which is required for unipolar budding during filamentous growth (Taheri et al., 2000; Cullen and Sprague, 2002) and for GEF recruitment during vegetative growth by the bud-site selection GTPase Rsr1p (Shimada et al., 2004). Sho1p and Bud8p were found to associate (Fig. 5 B). These results are consistent with the idea that Sho1p contributes to Bud8p-dependent recruitment of Cdc24p by a mechanism that requires MAPK activation. Sho1p and Cdc24p might interact by affiliation with bud-site selection proteins; however, the Sho1p-Cdc24p interaction was independent of Rsr1p (Fig. 5 A) and Bud8p (Fig. 5 C). Hyperactive alleles of SHO1, or its overexpression, induced hyperpolarized growth in a manner that was partially independent of bud-site selection cues and the MAPK pathway (Fig. 5 D). These results indicate that Sho1p may also have a function in stabilization of Cdc24p at polarized sites.
###end p 27
###begin p 28
###xml 0 99 0 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sho1 interacts with Cdc24p and Bud8p and contributes to Cdc24p polarization by multiple mechanisms.</bold>
###xml 449 453 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHO1</italic>
###xml 461 471 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ste12&#916;</italic>
###xml 477 486 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rsr1&#916;</italic>
Sho1 interacts with Cdc24p and Bud8p and contributes to Cdc24p polarization by multiple mechanisms. (A) Sho1p and Cdc24p interact by co-IPT analysis. Proteins were tagged and precipitated with the indicated epitopes. (B) Sho1p and Bud8p interact by co-IPT analysis. (C) The interaction between Sho1p and Cdc24p is independent of Bud8p. Molecular mass standards (kD) are indicated on the left of the gel blots. (D) The length of cells overexpressing SHO1 in WT, ste12Delta, and rsr1Delta strains compared with a WT control. More than 50 cells were examined for each strain. Error bars represent the standard deviation of the values derived from at least two separate experiments.
###end p 28
###begin title 29
Summary
###end title 29
###begin p 30
###xml 179 196 179 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">Schweisguth, 2004</xref>
###xml 217 235 217 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">Barry et al., 2006</xref>
###xml 506 534 506 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Liaudet-Coopman et al., 2006</xref>
###xml 56 61 <span type="species:ncbi:4932">yeast</span>
We have identified a novel MAPK activation mechanism in yeast by processing and release of the inhibitory domain of Msb2p. Cleavage-dependent activation has been found for Notch (Schweisguth, 2004) and PAR receptors (Barry et al., 2006) and may extend to other members of the signaling mucin family. We have also identified a glycosylphosphatidylinositol (GPI)-anchored aspartyl protease that regulates Msb2p function. In mammalian cells, secreted aspartyl proteases are coregulated with signaling mucins (Liaudet-Coopman et al., 2006), which suggests the possibility that aspartyl proteases may be general regulators of signaling mucin receptors.
###end p 30
###begin title 31
Materials and methods
###end title 31
###begin title 32
Strains, plasmids, and microbiological techniques
###end title 32
###begin p 33
###xml 180 199 177 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Cullen et al., 2000</xref>
###xml 202 211 199 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FUS1-HIS3</italic>
###xml 243 252 240 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FUS1-lacZ</italic>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast strains are listed in Table S1 (available at ) and plasmids in Table S2. beta-galactosidase assays were performed as described and represent at least two independent trials (Cullen et al., 2000). FUS1-HIS3 expression was used to confirm FUS1-lacZ reporter data and was measured by spotting equal amounts of cells onto synthetic medium lacking histidine and containing 4-amino-1,2,4-triazole. Unless otherwise indicated, the locations of the epitope tags are at 500 residues for Msb2p and at 367 residues for Sho1p. HA-Msb2p-GFP contains a GFP epitope at position 1,306 residues. All fusion proteins were functional with respect to filamentation phenotypes and MAPK reporter activity. Other functional C-terminal Msb2p fusions show similar processing intermediates as Msb2p-GFP.
###end p 33
###begin p 34
###xml 66 87 66 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Sambrook et al., 1989</xref>
###xml 89 106 89 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Rose et al., 1990</xref>
###xml 167 190 167 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Chant and Pringle, 1995</xref>
###xml 242 266 242 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">Cullen and Sprague, 2002</xref>
###xml 313 337 313 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Cullen and Sprague, 2000</xref>
###xml 365 387 365 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Roberts and Fink, 1994</xref>
###xml 420 439 420 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">Gimeno et al., 1992</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast and bacterial strains were manipulated by standard methods (Sambrook et al., 1989; Rose et al., 1990). The budding pattern was based on established methodology (Chant and Pringle, 1995) and by visual inspection as described previously (Cullen and Sprague, 2002) using the single cell invasive growth assay (Cullen and Sprague, 2000). The plate-washing assay (Roberts and Fink, 1994) and pseudohyphal growth assay (Gimeno et al., 1992) were performed as described previously.
###end p 34
###begin p 35
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSB2</italic>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">msb2</italic>
###xml 214 232 210 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">Ramer et al., 1992</xref>
###xml 239 243 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSB2</italic>
###xml 311 314 307 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL</italic>
###xml 332 335 328 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL</italic>
###xml 444 448 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSB2</italic>
###xml 467 475 463 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSB2-GFP</italic>
###xml 553 557 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSB2</italic>
###xml 738 742 734 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ</italic>
###xml 826 846 822 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">Roberts et al., 2000</xref>
###xml 863 867 859 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 884 888 880 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ</italic>
###xml 963 982 959 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Laloux et al., 1994</xref>
###xml 990 998 986 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRE-lacZ</italic>
###xml 1087 1107 1083 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">Madhani et al., 1997</xref>
###xml 1279 1283 1275 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSB2</italic>
###xml 1368 1390 1364 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">Schneider et al., 1995</xref>
###xml 1414 1418 1410 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 1468 1487 1464 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Baudin et al., 1993</xref>
###xml 1489 1510 1485 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">Longtine et al., 1998</xref>
###xml 1564 1592 1560 1588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Goldstein and McCusker, 1999</xref>
The plasmid containing the MSB2 gene (pMSB2; PC1287) was identified in a genetic screen for high-copy suppressors of the signaling defect of an msb2Delta mutant (PC948) using a galactose-inducible plasmid library (Ramer et al., 1992). The MSB2 gene was expressed in the opposite orientation with respect to the GAL promoter and was GAL independent. Plasmid pHA-MSB2 (PC1456) was created by GAP repair using homologous recombination of plasmid pMSB2 in strain PC999. pMSB2-GFP was constructed by PCR amplification and insertion of the GFP cassette into pMSB2 at position 400 residues and was constructed by A. Mirando (University of Rochester Medical Center, Rochester, NY). Plasmids containing filamentous growth pathway targets fused to lacZ and plasmid V84 were provided by C. Boone (University of Toronto, Ontario, Canada; Roberts et al., 2000). Plasmid pIL30-URA3 containing FgTy-lacZ was provided by B. Errede (University of North Carolina, Chapel Hill, NC; Laloux et al., 1994), and pFRE-lacZ was provided by H. Madhani (University of California, San Francisco, San Francisco, CA; Madhani et al., 1997). Other plasmids containing versions of Sho1p were provided by H. Saito (University of Tokyo, Tokyo, Japan) and A. Davidson (University of Toronto). The HA fusions at the MSB2 locus were made at 500 residues or other regions of the Msb2p protein as indicated (Schneider et al., 1995). Gene disruptions and GAL1 promoter fusions were made by PCR-based methods (Baudin et al., 1993; Longtine et al., 1998), including the use of antibiotic resistant markers (Goldstein and McCusker, 1999). Integrations were confirmed by PCR analysis and phenotype.
###end p 35
###begin title 36
Protein analysis
###end title 36
###begin p 37
###xml 165 184 164 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Cullen et al., 2004</xref>
###xml 198 203 <span type="species:ncbi:10090">mouse</span>
###xml 248 252 <span type="species:ncbi:9925">goat</span>
Secreted proteins were analyzed from conditioned media that was passed through a 2-mum filter to remove cells. Western blots were performed as described previously (Cullen et al., 2004). Monoclonal mouse anti-HA antibodies (12CA5.16.4), monoclonal goat anti-GFP antibodies (Rockland Scientific International), and monoclonal antibodies to Dpm1p were used.
###end p 37
###begin title 38
Coimmunoprecipitation (co-IPT) analysis
###end title 38
###begin p 39
To examine the interaction between Sho1p and Cdc24p, co-IPT analysis was performed on extracts derived from PC1652. To measure the interaction in a strain lacking Rsr1p, co-IPT analysis was performed from extracts derived from PC2281. For the Sho1p-Bud8 interaction, PC2249 was transformed with pBUD8-GFP (PC1883) and a control plasmid.
###end p 39
###begin p 40
###xml 51 73 51 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Kemp and Sprague, 2003</xref>
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 363 364 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 631 632 624 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1006 1007 993 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1212 1213 1192 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1548 1549 1527 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1904 1905 1879 1880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
Co-IPT analysis was based on previous methodology (Kemp and Sprague, 2003). 100 ml of exponentially grown cells were pelleted at room temperature for 5 min at 3,000 g. Cells were resuspended in 4 ml of DTT buffer (50 mM Tris-HCl, pH 7.5, and 10 mM DTT) and incubated at room temperature for 15 min. The cells were pelleted at room temperature for 5 min at 15,800 g, and pellets were resuspended in 3.75 ml of spheroplast buffer (1.2 M sorbitol, 50 mM potassium phosphate, pH 7.4, 1 mM MgCl, and 250 mug/ml of zymolyase) and incubated in 30degreesC on an end-to-end rotator for 1 h. Spheroplasts were centrifuged for 2 min at 2,300 g. Cell pellets were washed in 1 ml of 1.2 M sorbitol and centrifuged for 4 min at low speed as before. Spheroplasts were lysed in 1 ml of ice-cold IPT buffer (50 mM Tris-HCl, pH 8, 1 mM EDTA, 50 mM NaCl, and 1.5% Igepal CA-630) supplemented with 1x protease inhibitor cocktail, EDTA free, and 1 mM PMSF before use. Lysates were centrifuged at 4degreesC for 20 min at 15,800 g. Supernatants were precleared by incubating with 75 mul of immobilized Protein G plus (Thermo Fisher Scientific) on an end-to-end rotator for 30 min. Beads were pelleted at 4degreesC for 10 min at 15,800 g. The protein concentration of precleared supernatants was determined by the Bradford Coomassie blue assay. 5-7 mg of proteins were immunoprecipitated with a polyclonal antibody in 1:75 dilution for 1 h, and complexes were pulled down by adding 75 mul of protein G and incubating for another 1 h. IPT complexes were pelleted at 15,800 g for 1 min. Beads were washed in IPT buffer three times for 1 min each time. 50 mul of Thorner buffer (8 M urea, 5% SDS, 40 mM Tris-HCl, pH 6.8, 0.1 M EDTA, 0.4 mg/ml Bromophenol blue, and 1% beta-mercaptoethanol) was added to beads, and IPT complexes were released from beads by boiling for 10 min. Beads were removed by centrifuging for 1 min at 15,800 g, after which the pellet was discarded. Supernatants (protein complexes) were either immediately processed by SDS-PAGE or frozen at -80degreesC.
###end p 40
###begin title 41
Microscopy
###end title 41
###begin p 42
Differential interference contrast and fluorescence microscopy of the GFP protein using FITC filter sets were performed using an fluorescent microscope (Axioplan 2; Carl Zeiss, Inc.) with a Plan-Apochromat 100x/1.4 (oil) objective (NA 0.17; Carl Zeiss, Inc.). For most experiments, cells were visualized by resuspending in water at 25degreesC. Digital images were obtained with a camera (Axiocam MRm; Carl Zeiss, Inc.). Axiovision 4.4 software (Carl Zeiss, Inc.) was used for image acquisition and analysis. Images were further analyzed in Photoshop (Adobe), where adjustments of brightness and contrast were made.
###end p 42
###begin title 43
SHO1 mutagenesis
###end title 43
###begin p 44
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHO1</italic>
###xml 124 143 124 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Rose and Fink, 1987</xref>
###xml 198 202 198 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sho1</italic>
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHO1</italic>
###xml 267 286 267 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Marles et al., 2004</xref>
###xml 316 325 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sho1&#916;</italic>
###xml 443 452 439 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FUS1-HIS3</italic>
###xml 487 496 483 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ste4&#916;</italic>
###xml 517 536 505 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Cullen et al., 2004</xref>
###xml 117 122 <span type="species:ncbi:4932">yeast</span>
Mutagenesis of the SHO1 gene was performed by plasmid mutagenesis based on a protocol for direct transformation into yeast (Rose and Fink, 1987). Efficiency was 5% as determined by the frequency of sho1 null mutations. An allele of SHO1 was used (S171C and NF300GSA; Marles et al., 2004) that fully complemented the sho1Delta mutant. Hyperactive alleles were selected on media lacking histidine and containing 4-amino-1,2,4-triazole using the FUS1-HIS3 reporter (PC1531) integrated into ste4Delta Sigma1278b strains (Cullen et al., 2004). 283,680 URA3+ colonies were screened and approximately100 ATA resistant isolates were identified, of which six were plasmid dependent; five of the six resulted in the P120L change and were identified in separate pools. Plasmid-dependent mutations were analyzed by sequence analysis at the Roswell Park sequencing facility.
###end p 44
###begin title 45
Western blots and protein analysis
###end title 45
###begin p 46
###xml 885 904 867 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Hansen et al., 1997</xref>
###xml 992 1009 974 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">Rost et al., 2004</xref>
Proteins were separated by SDS-PAGE on 10% precast gels (Bio-Rad Laboratories) and transferred to nitrocellulose membranes (protran BA85, VWR International, LLC). Membranes were incubated in 10 ml of blocking buffer (5% nonfat dry milk, 10 mM Tris-HCl, pH 8, 150 mM NaCl, and 0.05% Tween 20) either for 1 h at 25degreesC or 16 h at 4degreesC. Preblocked membranes were incubated in blocking buffer containing primary antibodies for 1 h at 25degreesC. Blots were washed three times for 5 min each in TBST (10 mM Tris-HCl, pH 8, 150 mM NaCl, and 0.05% Tween 20). Blots were incubated in HRP-conjugated secondary antibodies for 1 h at room temperature. ECL Plus Western blotting reagent (GE Healthcare) was used to detect proteins. Predicted N- and O-glycosylation sites were determined by O-GLYCBASE version 2.0 (Center for Biological Sequence Analysis, Technical University of Denmark; Hansen et al., 1997). The secondary structure of Msb2p domains was determined by PROF and NORS algorithms (Rost et al., 2004).
###end p 46
###begin title 47
Online supplemental material
###end title 47
###begin p 48
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yps</italic>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHO1</italic>
###xml 120 125 120 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P120L</sup>
###xml 234 239 <span type="species:ncbi:4932">yeast</span>
Fig. S1 shows the secretion defect of Msb2p in yps and cell wall mutant combinations. Fig. S2 shows analysis of the SHO1P120L allele. Fig. S3 shows genetic data between filamentous growth pathway components and Cdc24p. Table S1 lists yeast strains. Table S2 lists plasmids used in this study. Table S3 shows analysis of secretion of the Msb2p-HA protein in protease mutants. Online supplemental material is available at .
###end p 48
###begin title 49
Supplementary Material
###end title 49
###begin title 50
[Supplemental Material Index]
###end title 50
###begin p 51
We thank B. Errede, H. Saito, A. Davidson, C. Boone, and H. Madhani for reagents. We also give thanks to B. Andrews, E. Bi, J. Berry, J. Thorner, J. Pringle, P. Pryciak, D. Lew, and R. Fuller for helpful discussions.
###end p 51
###begin p 52
P.J. Cullen is supported by grants from the National Institutes of Health (1R03DE018425-01), American Cancer Society (TBE-114083), and the American Heart Association (GM 0535393T). D.J. Krysan is supported by a National Institutes of Health grant (K08AI062978).
###end p 52

